Clinical Trial
Phase II study of adriamycin (NSC-123127) in patients with metastatic melanoma
- PMID: 769962
Item in Clipboard
Clinical Trial
Phase II study of adriamycin (NSC-123127) in patients with metastatic melanoma
Cancer Chemother Rep.
1975 Nov-Dec.
No abstract available
Similar articles
-
Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037).Cancer Chemother Rep. 1973 Nov-Dec;57(4):437-45. Cancer Chemother Rep. 1973. PMID: 4586951 Clinical Trial. No abstract available.
-
Adriamycin (NSC-123127) in combination with cyclophosphamide (NSC-26271): a phase I and II evaluation.Cancer Chemother Rep. 1974 Nov-Dec;58(6):919-26. Cancer Chemother Rep. 1974. PMID: 4614899 Clinical Trial. No abstract available.
-
Combination chemotherapy with adriamycin (NSC-123127) in metastatic mammary carcinoma.Cancer Chemother Rep. 1974 Mar-Apr;58(2):251-3. Cancer Chemother Rep. 1974. PMID: 4598244 Clinical Trial. No abstract available.
-
Phase II trial of 4'-epi-doxorubicin in metastatic melanoma.Cancer Treat Rep. 1984 Dec;68(12):1509-10. Cancer Treat Rep. 1984. PMID: 6595059 No abstract available.
-
Review of docetaxel/doxorubicin combination in metastatic breast cancer.Oncology (Williston Park). 1997 Aug;11(8 Suppl 8):31-3. Oncology (Williston Park). 1997. PMID: 9364539 Review.
Cited by
-
A phase II, open label, monotherapy study of liposomal doxorubicin in patients with metastatic malignant melanoma.Invest New Drugs. 2007 Apr;25(2):155-9. doi: 10.1007/s10637-006-9002-y. Epub 2006 Sep 7. Invest New Drugs. 2007. PMID: 16957835 Clinical Trial.
-
Chemotherapy of malignant melanoma.World J Surg. 1979 Jul 30;3(3):321-8. doi: 10.1007/BF01556584. World J Surg. 1979. PMID: 382646 Review. No abstract available.
-
Colony growth and clonogenic cell survival in human melanoma xenografts treated with chemotherapy.Br J Cancer. 1980 Sep;42(3):438-47. doi: 10.1038/bjc.1980.256. Br J Cancer. 1980. PMID: 7426346 Free PMC article.